Completed PHASE2 INTERVENTIONAL 1-arm NCT02735499

Instillation of Botox in the Bladder in Women With Overactive Bladder (OAB)

Bladder Instillation of Botox With EMDA for OAB - a Pilot Study

Sponsor: South-Eastern Norway Regional Health Authority

Updated 8 times since 2017 Last updated: Nov 21, 2018 Started: Mar 31, 2016 Primary completion: Oct 31, 2016 Completion: Oct 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Overactive Bladder and is currently completed. South-Eastern Norway Regional Health Authority leads this study, which shows 8 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Dec 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Dec 2018 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE2

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

South-Eastern Norway Regional Health Authority
The Hospital of Vestfold

Data source: The Hospital of Vestfold

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tønsberg, Norway